Top Markets
Coin of the day
Abliva AB (publ) Abliva AB (publ)

Abliva AB (publ)

ABLI
Rankning i aktier #22998
Abliva AB (publ), a Swedish biopharmaceutical company founded in Lund in 2000,... Abliva AB (publ), a Swedish biopharmaceutical company founded in Lund in 2000, focuses on developing innovative therapeutic solutions for primary mitochondrial diseases. Its pipeline includes KL1333, currently in Phase 2/3 clinical trials for the long-term management of these conditions, and NV354, which is preparing for clinical studies targeting primary mitochondrial diseases specifically linked to Complex I deficiency. The company is also advancing NeuroSTAT through a Phase 1b/2a clinical study for the treatment of traumatic brain injury. Abliva maintains strategic partnerships with entities such as Isomerase, Yungjin Pharm, the University of Pennsylvania, Children's Hospital of Philadelphia, and Oroboros Instruments. The firm rebranded as Abliva AB (publ) in May 2020, having previously been known as NeuroVive Pharmaceutical AB (publ).
Aktiekurs
$0.04959193
Senast synkroniserad: 2025-03-17
Marknadsvärde
$79.94M
Förändring (1 dag)
13.49%
Förändring (1 år)
0.00%
Land
SE
Handel Abliva AB (publ) (ABLI)

Kategori

Historik för aktiesplit för Abliva AB (publ) (ABLI)
Aktien Abliva AB (publ) (symbol: ABLI) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 22, 2026.
En ABLI-aktie köpt före Aug 22, 2026 motsvarar nu 0 ABLI-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH